Oleanolic acid prevents progression of streptozotocin induced diabetic nephropathy and protects renal microstructures in Sprague Dawley rats - PubMed (original) (raw)

Oleanolic acid prevents progression of streptozotocin induced diabetic nephropathy and protects renal microstructures in Sprague Dawley rats

Vishal K Dubey et al. J Pharmacol Pharmacother. 2013 Jan.

Abstract

Objective: To study the effect of oleanolic acid (OA) on streptozotocin induced diabetic nephropathy in Sprague Dawley rats.

Materials and methods: Four weeks after intra-peritoneal injection of streptozotocin (STZ; 55 mg/kg), the rats with proteinuria were grouped as: Control (non-diabetic, treated orally with vehicle), diabetic control (treated orally with vehicle) and three diabetic groups receiving 20, 40 and 60 mg/kg/day oral doses of OA. At the end of 8 weeks, urine and serum samples from the rats were processed for determination of creatinine, BUN and GFR. The kidney samples were processed for determination of weight changes, oxidative stress related parameters like catalase, superoxide dismutase and reduced glutathione levels. A part of one kidney from each rat was used for transmission electron microscopy (TEM).

Result: As evident in TEM, OA inhibited the nephropathy induced alterations in podocyte integrity, basement membrane thickness and spacing between the podocytes at 60 mg/kg dose. It increased GFR and reduced oxidative stress in the kidneys in a dose dependent manner. These findings conclusively demonstrate the efficacy of OA in diabetic nephropathy. Significant decrease in the oxidative stress in kidneys indicates the role of anti-oxidant mechanisms in the effects of OA. However, OA is known to act through multiple mechanisms like inhibition of the generation of advanced glycation end products and improving the insulin secretion. These mechanisms might have contributed to its efficacy.

Conclusion: These results conclusively demonstrate the efficacy of OA in diabetic nephropathy through its possible antioxidant activity.

Keywords: Electron microscopy; glomerular basement membrane; pentacyclic triterpenoid; podocytes.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1

Figure 1

Oleanolic acid protects rats kidneys from histological changes induced during diabetic nephropathy Magnification: ×400 Arbritary gradings given in parenthesis by a blinded observer indicate: (+++): Very severe, (++): severe. (+): Only detectable, (-): Absent

Figure 2

Figure 2

Oleanolic acid protects rats kidneys from ultramicroscopic changes associated with diabetic nephropathy. Magnification: 5600×, BM : Basement membrane, PC : podocyte, MV : Microvasculature

Figure 3

Figure 3

Oleanolic acid ameliorated the symptoms of streptozotocin induced diabetes in rats

Similar articles

Cited by

References

    1. Liby KT, Yore MM, Sporn MB. Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer. Nat Rev Cancer. 2007;7:357–69. - PubMed
    1. Dzubak P, Hajduch M, Vydra D, Hustova A, Kvasnica M, Biedermann D, et al. Pharmacological activities of natural triterpenoids and their therapeutic implications. Nat Prod Rep. 2006;23:394–441. - PubMed
    1. Sporn MB, Liby KT, Yore MM, Suh N, Albini A, Honda T, et al. Platforms and networks in triterpenoid pharmacology. Drug Dev Res. 2007;68:174–82.
    1. Liu J. Oleanolic acid and urosolic acid: Research perspectives. J Ethnopharmacol. 2005;100:92–4. - PubMed
    1. Sultana N, Ata A. Oleanolic acid and related derivatives as medicinally important compounds. J Enzyme Inhib Med Chem. 2008;23:739–56. - PubMed

LinkOut - more resources